Cross Cancer Institute /ID# 167603
Edmonton, Alberta T6G 1Z2
0 studies enrolling now ยท 1 studies all time
What they study most
Advanced Solid Tumors
Studies at this site
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
โ Completed